PDA is the arginate-salt form of BPC-157 — functionally the same molecule (acetate vs arginate), relabeled and sold to sidestep BPC-157’s FDA category-2 compounding ban. Per Dr. Bakri, it is BPC-157. See BPC-157 for all mechanism, evidence, dosing, and safety.